GlassScriptPhysician profile
Matthew D Murphey
NPI 1316104235
$3,675.34
in general payments reported to CMS, 2019-2025
11 companies · $349 in 2025
The $349 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $495 · 2020: $478 · 2021: $876 · 2022: $844 · 2023: $300 · 2024: $332 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $982.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $982.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $2,392.45 | 2019-2025 | Apligraf, Puraply Wound Matrix, Affinity |
| Stryker Corporation | $606.98 | 2021-2025 | Ortholoc 2 Lapifuse, Citrefix, Augment Injectable |
| Smith+Nephew, INC. | $310.29 | 2019-2023 | Collagenase Santyl |
| Abbvie INC. | $96.86 | 2024-2025 | |
| Medline Industries LP | $86.80 | 2022 | |
| Triad Life Sciences INC. | $47.78 | 2022 | |
| Crossroads Extremity Systems, LLC | $42.08 | 2019 | |
| Horizon Therapeutics Plc | $28.57 | 2019 | |
| Bsn Medical INC | $26.74 | 2022 | |
| Integra Lifesciences Corporation | $21.03 | 2020 | |
| Paratek Pharmaceuticals, INC. | $15.76 | 2025 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Murphey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.